TIAA CREF Investment Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-201,207
| Closed | -$3.91M | – | 3199 |
|
|
2018
Q1 | $3.91M | Sell |
201,207
-13,462
| -6% | -$264K | ﹤0.01% | 1713 |
|
|
2017
Q4 | $3.57M | Sell |
214,669
-43,199
| -17% | -$792K | ﹤0.01% | 1814 |
|
|
2017
Q3 | $5.24M | Buy |
257,868
+19,395
| +8% | +$371K | ﹤0.01% | 1592 |
|
|
2017
Q2 | $3.84M | Buy |
238,473
+2,463
| +1% | +$36.4K | ﹤0.01% | 1767 |
|
|
2017
Q1 | $2.99M | Sell |
236,010
-9,232
| -4% | -$112K | ﹤0.01% | 1902 |
|
|
2016
Q4 | $3.25M | Buy |
245,242
+3,721
| +2% | +$63.6K | ﹤0.01% | 1907 |
|
|
2016
Q3 | $5.72K | Sell |
241,521
-1,897
| -0.8% | -$51K | ﹤0.01% | 1517 |
|
|
2016
Q2 | $7.01M | Buy |
243,418
+2,133
| +0.9% | +$69.5K | 0.01% | 1300 |
|
|
2016
Q1 | $7.73M | Sell |
241,285
-11,116
| -4% | -$391K | 0.01% | 1212 |
|
|
2015
Q4 | $10.8M | Sell |
252,401
-6,804
| -3% | -$272K | 0.01% | 1026 |
|
|
2015
Q3 | $9.13M | Sell |
259,205
-14,488
| -5% | -$653K | 0.01% | 1103 |
|
|
2015
Q2 | $12.6M | Sell |
273,693
-8,815
| -3% | -$418K | 0.01% | 1003 |
|
|
2015
Q1 | $13.2M | Sell |
282,508
-2,738
| -1% | -$109K | 0.01% | 968 |
|
|
2014
Q4 | $9.04M | Sell |
285,246
-21,043
| -7% | -$616K | 0.01% | 1187 |
|
|
2014
Q3 | $7.26M | Sell |
306,289
-3,624
| -1% | -$92.8K | 0.01% | 1324 |
|
|
2014
Q2 | $9.29M | Sell |
309,913
-9,044
| -3% | -$244K | 0.01% | 1211 |
|
|
2014
Q1 | $8.43M | Sell |
318,957
-4,840
| -1% | -$121K | 0.01% | 1240 |
|
|
2013
Q4 | $8.14M | Sell |
323,797
-22,896
| -7% | -$511K | 0.01% | 1288 |
|
|
2013
Q3 | $7.11M | Sell |
346,693
-62,381
| -15% | -$1.29M | 0.01% | 1327 |
|
|
2013
Q2 | $8.16M | Buy |
+409,074
| New | +$7.26M | 0.01% | 1176 |
|
TIAA CREF Investment Management's IPXL Position: Q2 2018 in Review
TIAA CREF Investment Management sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 201,207 shares — an estimated $3.91M sold.
TIAA CREF Investment Management first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $13.2M in Q1 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- TIAA CREF Investment Management reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- TIAA CREF Investment Management sold 201,207 Impax Laboratories, Inc. shares in Q2 2018, an estimated $3.91M.
- TIAA CREF Investment Management first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- TIAA CREF Investment Management's Impax Laboratories, Inc. position peaked at $13.2M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on TIAA CREF Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.